
Court analyzes whether the substance is a medicine or a health product, which directly impacts the funding and access to cannabidiol by the SUS

Debates on medicinal cannabis continue deeply at Cannabis Connection 2025 in November and at the Brazilian Medicinal Cannabis Congress in May 2026, both in São Paulo.